What does DERMASKIN do?

DERMASKIN is a rental company in Chaudfontaine. Private Limited, started on 1 December 2019, 1 establishment.

What is the address of DERMASKIN?

The registered office of DERMASKIN is located at Drève St-Lambert 22, 4052 Chaudfontaine.

Is DERMASKIN still active?

No. The CBE lists DERMASKIN with legal situation “Opening faillissement”. The date of the court ruling is published in the Belgian Official Gazette; the register does not carry it.

Is DERMASKIN registered on Peppol?

No, DERMASKIN is currently not registered on the Peppol network.

What is the enterprise number of DERMASKIN?

The enterprise number of DERMASKIN is BE0738605114.

When was DERMASKIN founded?

DERMASKIN was founded on 1 December 2019.

Who are the directors of DERMASKIN?

According to the 2025 annual accounts, the directors of DERMASKIN are: Béatrice GUIOT, Jean-François IRLIK.

Is DERMASKIN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Opening faillissement according to the CBE, started on 1 December 2019; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DERMASKIN make in 2025?

DERMASKIN posted a profit after taxes of € 6,893 in financial year 2025.

What is the revenue of DERMASKIN?

As a small company, DERMASKIN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -1,224.

DERMASKIN (Private Limited) - Chaudfontaine

Dossier DERMASKIN, printed on 16 September 2026 from databakkes.be/en/0738605114/dermaskin. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Legal situation KBO

Opening faillissement according to the CBE.

Financials

Financial year 2025

DERMASKIN from Chaudfontaine, company number BE0738605114, closed financial year 2025 with a result of € 6,893 after tax. For that financial year DERMASKIN recorded a gross margin of € -1,224 and equity of € 16,955. Compared with financial year 2024, the result moved from € -8,442 to € 6,893. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 29, 2026.

What it is worth Growing

€ 16,955

▲ 68% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 6,893

▲ still € 8,442 loss in 2024

Profit after tax over the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 8,955.

Debts at end 2025

Bank debt

€ 67

▼ 64% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 5,033

▲ 32% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -491 Gross margin 2022: € -491 First fiscal year in the series	€ 0 Gross margin 2023: € 0 ▲ € 491 vs 2022 (€ -491) Favourable step	€ 6,873 Gross margin 2024: € 6,873 Unchanged (€ 0) Favourable step	€ -1,224 Gross margin 2025: € -1,224 ▼ € 8,098 vs 2024 (€ 6,873) Unfavourable step	▼ € 8,098
Profit after taxes	€ -3,117 Profit after taxes 2022: € -3,117 First fiscal year in the series	€ -4,361 Profit after taxes 2023: € -4,361 ▼ € 1,244 vs 2022 (€ -3,117) Unfavourable step	€ -8,442 Profit after taxes 2024: € -8,442 ▼ € 4,081 vs 2023 (€ -4,361) Unfavourable step	€ 6,893 Profit after taxes 2025: € 6,893 ▲ € 15,334 vs 2024 (€ -8,442) Favourable step	▲ € 15,334
Equity	€ 22,865 Equity 2022: € 22,865 First fiscal year in the series	€ 18,504 Equity 2023: € 18,504 ▼ 19% vs 2022 (€ 22,865) Unfavourable step	€ 10,063 Equity 2024: € 10,063 ▼ 46% vs 2023 (€ 18,504) Unfavourable step	€ 16,955 Equity 2025: € 16,955 ▲ 68% vs 2024 (€ 10,063) Favourable step	▲ 68%
Total debts	€ 9,830 Total debts 2022: € 9,830 First fiscal year in the series	€ 9,516 Total debts 2023: € 9,516 ▼ 3% vs 2022 (€ 9,830) Favourable step	€ 10,796 Total debts 2024: € 10,796 ▲ 13% vs 2023 (€ 9,516) Unfavourable step	€ 9,575 Total debts 2025: € 9,575 ▼ 11% vs 2024 (€ 10,796) Favourable step	▼ 11%
Cash	€ 10,376 Cash 2022: € 10,376 First fiscal year in the series	€ 9,698 Cash 2023: € 9,698 ▼ 7% vs 2022 (€ 10,376) Unfavourable step	-	-
Retained profit	€ 14,865 Retained profit 2022: € 14,865 First fiscal year in the series	€ 10,504 Retained profit 2023: € 10,504 ▼ 29% vs 2022 (€ 14,865) Unfavourable step	€ 2,063 Retained profit 2024: € 2,063 ▼ 80% vs 2023 (€ 10,504) Unfavourable step	€ 8,955 Retained profit 2025: € 8,955 ▲ € 6,893 vs 2024 (€ 2,063) Favourable step	▲ € 6,893
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 185 Bank debt 2024: € 185 Unchanged (€ 0) Unfavourable step	€ 67 Bank debt 2025: € 67 ▼ 64% vs 2024 (€ 185) Favourable step	▼ 64%
Balance sheet total	€ 32,695 Balance sheet total 2022: € 32,695 First fiscal year in the series	€ 28,020 Balance sheet total 2023: € 28,020 ▼ 14% vs 2022 (€ 32,695) Unchanged	€ 20,859 Balance sheet total 2024: € 20,859 ▼ 26% vs 2023 (€ 28,020) Unchanged	€ 26,530 Balance sheet total 2025: € 26,530 ▲ 27% vs 2024 (€ 20,859) Unchanged	▲ 27%

Key figures of DERMASKIN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DERMASKIN?

What happened at DERMASKIN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

DERMASKIN is active according to the CBE. Legal situation: Opening faillissement.

May 29, 2026 New annual accounts for financial year 2025: profit of € 6,893. Source: NBB ↗
Dec 1, 2019 New establishment in Chaudfontaine. KBO
Dec 1, 2019 Start of the company according to the CBE. KBO
2019 Béatrice GUIOT became a director. NBB
2019 Jean-François IRLIK became a director. NBB

In short

From € 3,117 loss in 2022 to € 6,893 profit in 2025.

Paid € 12,010 in corporate taxes since 2022.

Best year ever: 2025, with € 6,893 profit.

Original PDFs at the National Bank ↗

A new publication or filing at DERMASKIN? We notify you, reason included.

Follow DERMASKIN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Béatrice GUIOT Jean-François IRLIK

DERMASKIN

Behind DERMASKIN are Béatrice GUIOT and Jean-François IRLIK.

See the full network in the app

Directors

According to the 2025 annual accounts

Béatrice GUIOT

Director

since 2019

Jean-François IRLIK

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Drève St-Lambert 22

4052 Chaudfontaine

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

FARMAFYT HEALTHCARE

€ 145,824 gross margin · 2025

ENNEO

€ -10,355 gross margin · 2025

Farmafyt

€ 272,654 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0738.605.114

VAT number

BE 0738.605.114

Registered office

Drève St-Lambert 22, 4052 Chaudfontaine

Names & denominations

DERMASKIN

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Opening faillissement

Start date

1 December 2019

Peppol

Not registered

Activities · NACE

Verhuur en lease van andere machines en werktuigen en andere materiële goederen

Schoonheidsverzorging en andere schoonheidsbehandelingen

Overige vormen van onderwijs

Activiteiten van kuuroorden, sauna’s en stoombaden

Overige detailhandel in nieuwe artikelen neg

Overige zakelijke dienstverlening, neg

Schoonheidsverzorging

Sauna's, solaria, baden enz.

View on CBE Public ↗ Annual accounts (NBB) ↗

DERMASKIN

Warning lights

Financials

What happened to DERMASKIN?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions